Decision-curve analysis showed that Mehralivand EPE grades combined with MRI were potentially useful for predicting an EPE in patients with PCa when added to clinical characteristics, such as age, PSA, prostate volume, the percentage of positive biopsy cores, and clinical stage. The gene discussed is KLK3; the disease is posterior cortical atrophy.